Idera Pharmaceuticals, Inc. - Special Call

11/9/2017 9:00

Llamada en conferencia Idera Pharmaceuticals Inc

Idera Pharmaceuticals Inc Conference call or earnings call will be held on 11-sep-2017 via an 800 number (toll-free). During the earnings conference call's session Idera Pharmaceuticals Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Idera Pharmaceuticals Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for oncology and rare diseases. We use two distinct proprietary drug discovery technology platforms to design and develop drug candidates: our Toll-like receptor, or TLR, targeting technology and our third-generation antisense, or 3GA, technology, which we previously referred to as our GSO technology. We developed these platforms based on our scientific expertise and pioneering work with synthetic oligonucleotides as therapeutic agents. Using our TLR targeting technology, we design synthetic oligonucleotide-based drug candidates to modulate the activity of specific TLRs. In addition, using our 3GA technology, we are developing drug candidates to turn off the messenger RNA, or mRNA, associated with disease causing genes.    
Leer más Llamada en conferencia

Idera Pharmaceuticals Inc (IDRA)

167 Sidney Street, Cambridge Massachusetts 02139, United States